Clinical trial
A Prospective, Multicenter, Randomized Clinical Investigation Evaluating GATT-Patch for Hemostasis During Minimally Invasive Liver and Gallbladder Surgery
NCT05900037 is registered in ClinicalTrials.gov with GATT Technologies BV as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized Clinical Investigation Evaluating GATT-Patch for Hemostasis During Minimally Invasive Liver and Gallbladder Surgery
- Lead sponsor
- GATT Technologies BV
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 2, 2023
- Completion date
- August 5, 2025
- Enrollment
- 53 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
gallbladder diseases, hemorrhage, surgical, intraoperative bleeding, liver diseases